007370 — Jin Yang Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapContrarian

Annual cashflow statement for Jin Yang Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	1,647	3,677	9,538	12,308	12,659
Depreciation
Amortisation
Non-Cash Items	871	-1,648	902	-70.9	-920
Unusual Items
Other Non-Cash Items
Changes in Working Capital	1,095	2,111	-10,622	-7,081	-5,861
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	5,727	6,245	1,971	7,448	8,534
Capital Expenditures	-752	-1,371	-2,723	-4,641	-1,534
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	1,209	2,743	-1,555	-8,192	4,769
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	457	1,372	-4,278	-12,833	3,236
Financing Cash Flow Items	—	100	100	-1,700	-110
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-4,559	-4,153	8,852	-5,581	-7,404
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,625	3,464	6,544	-10,966	4,365